In today's episode, Dr. John Gore and Dr. Scott Tykodi discuss metastatic kidney cancer and the Kidney Cancer Multispecialty Clinic, or KCMC, at SCCA.

Dr. Mohammed Sorror discusses Bone Marrow Transplantations (or BMT), particularly for older patients, and its benefits.

The sarcoma treatment landscape is changing quickly and dramatically, with a growing number of FDA-approved drugs and clinical trials offering new hope and improving outcomes for patients whose treatment options were very limited just a few years ago.

In this three-person panel, Dr. David Maloney, Katie Gieseke, and Hannah Alo explain CAR T-cell therapy, why someone would need this, and when someone should be referred to it.

Dr. Jonathan Sham discusses pancreas cancer, the Appleby procedure, and who can benefit from this.

Jennie Crews, MD, MMM, FACP, Jason Lukas, MD, PhD and AnnaLiisa McGlinn, MD discuss how the Seattle Cancer Care Alliance is committed to bringing world-class cancer treatment to patients in their own communities.

Dr. Mazyar Shadman will focus on Chronic Lymphocytic Leukemia, or CLL, and the treatment options available for standard-risk and high-risk patients.

Dr. Ryan C. Lynch will focus on Diffuse Large B Cell Lymphoma, or DLBCL, and the latest treatment options available.

Steven A. Pergam, MD, MPH, Medical Director, Infection Prevention at SCCA, and Catherine Liu, MD, Associate Medical Director, Infection Prevention, discuss how the center is addressing vulnerable populations during the COVID-19 crisis. They also explain how they've been able to minimize risk and exposure, as well as some of the key lessons learned after the city was on the forefront of the outbreak.